NCT04797819View on ClinicalTrials.gov

Serum Soluble ST2 and Plaque Vulnerability in Patients With Acute Coronary Syndrome

CompletedOBSERVATIONAL
Enrollment

120

Participants

Timeline

Start Date

January 1, 2019

Primary Completion Date

December 31, 2019

Study Completion Date

December 31, 2019

Conditions
Acute Coronary Syndrome
Interventions
DIAGNOSTIC_TEST

Coronary plaque components

Coronary plaque components were detected by CCTA method

Trial Locations (1)

Unknown

Cardiology, Ren Ji Hospital, Shanghai

All Listed Sponsors
lead

RenJi Hospital

OTHER

NCT04797819 - Serum Soluble ST2 and Plaque Vulnerability in Patients With Acute Coronary Syndrome | Biotech Hunter | Biotech Hunter